John Kenneth Jenkins
CIK: 0001742557
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Corbus Pharmaceuticals Holdings, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 10, 2026CRBP
Corbus Pharmaceuticals Holdings, Inc.
Sale(S)Direct4.8K shares at avg. $7.91$38K - May 19, 2026CRBP
Corbus Pharmaceuticals Holdings, Inc.
Award(A)Direct3.8K shares- - May 30, 2025CRBP
Corbus Pharmaceuticals Holdings, Inc.
Sale(S)Direct2.8K shares at avg. $7.35$20K - May 30, 2025CRBP
Corbus Pharmaceuticals Holdings, Inc.
Award(A)Direct4.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 10, 2026 | CRBP Corbus Pharmaceuticals Holdings, Inc. | Sale(S) | 4,800 | $7.91 | $37,986 | Direct |
| May 19, 2026 | CRBP Corbus Pharmaceuticals Holdings, Inc. | Award(A) | 3,800 | - | $0 | Direct |
| May 30, 2025 | CRBP Corbus Pharmaceuticals Holdings, Inc. | Sale(S) | 2,783 | $7.35 | $20,465 | Direct |
| May 30, 2025 | CRBP Corbus Pharmaceuticals Holdings, Inc. | Award(A) | 4,800 | - | - | Direct |
1-4 of 4 transactions
About Jenkins John Kenneth
Jenkins John Kenneth (SEC CIK 0001742557) files insider reports with the SEC as Director of Corbus Pharmaceuticals Holdings, Inc. (CRBP).
Signal8 holds 3 ownership filings by Jenkins John Kenneth, all Form 4s, filed between Jun 2, 2025 and Jun 11, 2026. Those filings report 4 transactions, from May 30, 2025 to Jun 10, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Jenkins John Kenneth's filings is in NORWOOD, MA.
Recent filings by Jenkins John Kenneth
Other insiders filing for Corbus Pharmaceuticals Holdings, Inc. (CRBP)
- Cormorant Asset Management, LP, Officer
- Ben Yong, Director
- Nicacio Leonardo Viana, Chief Medical Officer
- Saxena Nishant C, Chief Business Officer
- Cohen Yuval, Chief Executive Officer
- Moran Sean F., Chief Financial Officer